The therapy is designed to silence both PCSK9 and APOC3 genes simultaneously.

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-DIMER-PA, the company’s investigational RNA interference (RNAi ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The plasma D-dimer assay has been used, along with clinical prediction scores, to rule out ...

The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still spreading across many parts of the world, and clinicians are working on recognizing biomarkers ...

The severe acute respiratory syndrome corona virus 2 (SARS-COVID-19) was found in December 2019. From then onwards it has created havoc in the entire nation. More than 2 million people have been ...

Recently, Dompmartin and associates [4] reported a strong association between venous malformations and localized intravascular coagulopathy (LIC), especially in cases of large VMs, intramuscular VMs, ...

Several diagnostic strategies using ultrasound imaging, measurement of D-dimer, and assessment of clinical probability of disease have proved safe in patients with suspected deep-vein thrombosis, but ...

A study reported by researchers at NYU Langone Health’s Perlmutter Cancer Center and at the University of Oxford has offered up new insights into the workings of an immune cell surface receptor, ...